Send Tips

tips@dealbreaker.com or text
(646) 820-4847 all tips are anonymous

Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Bristol-Myers Squibb Completes Acquisition of Amylin Pharmaceuticals, Inc.
August 09, 2012
from Business Wire News Releases
Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Amylin Pharmaceuticals, Inc.
August 08, 2012
from Business Wire News Releases
Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, Inc.
August 01, 2012
from Business Wire News Releases
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristo
July 11, 2012
from Business Wire News Releases
Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with Its Proposed Merger with Bristol-Myers Squibb Company
July 10, 2012
from PR Newswire
Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
July 10, 2012
from Business Wire News Releases
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.
July 09, 2012
from PR Newswire
Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
July 07, 2012
from Business Wire News Releases
Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
July 03, 2012
from PR Newswire
Ryan & Maniskas, LLP Announces Investigation of Amylin Pharmaceuticals, Inc.
July 03, 2012
from Business Wire News Releases
Most Attractive Stocks: Bank of America, Amylin Pharmaceuticals, Bristol Myers Squibb, Constellation Brands, US Airways Group, and Alpha Natural Resources
July 03, 2012
from PR Newswire
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristo
July 02, 2012
from Business Wire News Releases
Harwood Feffer LLP Announces Investigation of Amylin Pharmaceuticals, Inc.
July 02, 2012
from PR Newswire
Rigrodsky & Long, P.A. Announces Investigation Of Amylin Pharmaceuticals, Inc. Buyout
July 02, 2012
from Business Wire News Releases
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amylin Pharmaceuticals Inc.
July 02, 2012
from Business Wire News Releases
Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
July 02, 2012
from PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
July 02, 2012
from PR Newswire
Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb’s Acquisition of Amylin Pharmaceuticals
June 29, 2012
from Business Wire News Releases
New Clinical Data Analyses Show Metreleptin Reduced Blood Glucose and Triglyceride Levels in Patients with Rare Forms of Lipodystrophy
June 25, 2012
from Business Wire News Releases
Once-Weekly BYDUREON™ Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
June 09, 2012
from Business Wire News Releases
BYDUREON™ Was Associated with Significant and Sustained Glycemic Control at Four Years
June 09, 2012
from Business Wire News Releases
SYMLIN® Use Helped Patients with Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
June 09, 2012
from Business Wire News Releases
BYDUREON™ Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients with Type 2 Diabetes
June 09, 2012
from Business Wire News Releases
BYETTA® Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl® in Patients with Type 2 Diabetes
June 09, 2012
from Business Wire News Releases
Amylin Pharmaceuticals to Present Data on BYDUREON™, BYETTA® and SYMLIN® at the American Diabetes Association 2012 Meeting
June 04, 2012
from Business Wire News Releases
Amylin Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference and Goldman Sachs 33rd Annual Global Healthcare Conference
May 29, 2012
from Business Wire News Releases
Equity Research on Most Popular Searches: VeriFone, Hewlett-Packard, eBay, Apple, J.C. Penney, and Amylin Pharmaceuticals
May 29, 2012
from PR Newswire
Today's Economic Outlook - Report Highlights Amylin Pharmaceuticals, Inc. and Wal-Mart Stores, Inc.
May 25, 2012
from Marketwired News Releases
Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
May 08, 2012
from Business Wire News Releases
Amylin Pharmaceuticals to Present at Deutsche Bank 37th Annual Health Care Conference
April 30, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here